Structure Therapeutics is progressing its obesity pipeline, with Phase 3 ACCOMPLISH trials of oral GLP-1 aleniglipron underway and positive Phase 1 single ascending dose data for oral amylin agonist ...
Source LinkStructure Therapeutics is progressing its obesity pipeline, with Phase 3 ACCOMPLISH trials of oral GLP-1 aleniglipron underway and positive Phase 1 single ascending dose data for oral amylin agonist ...
Source Link
Comments